Global Markets on Infectious Diseases

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

  • Mechanism of action of virus
  • Prevention and control of virus
  • Rabies
  • Malaria, Dengue fever, River blindness
  • Available vaccines

Related Conference of Global Markets on Infectious Diseases

December 07-08, 2020

8th World Summit on Allergy and Clinical Immunology

Prague, Czech Republic
December 07-07, 2020

2nd World Conference on Vaccine and Immunology

Singapore, Singapore
April 05-05, 2021

Tumor & Cancer Immunology and Pediatric-Oncology

Toronto, Canada
June 23-24, 2021

34th World Congress on Vaccines and Immunization

Osaka, Australia
October 14-15, 2021

13th Annual Conference on Cinical Immunology

Cape Town, Australia

Global Markets on Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in